[Chart courtesy of MarketWatch.com] Moving the markets More positive vaccine news coupled with newfound hope for a strong economic recovery next year and some easing of political uncertainty, although the election has not been decided yet, combined forces to propel the markets higher. A well-timed short-squeeze lent an assist again. This weighed heavily: Traders also cheered on Tuesday the increasing …
Vaccine News + Short Squeeze = Higher Stocks
[Chart courtesy of MarketWatch.com] Moving the markets The futures markets pointed to higher equity prices, as AstraZeneca became the latest competitor in the Covid-19 vaccine creation fest saying its product would be 90% effective. News over the weekend that the first vaccine could be available within weeks after the anticipated FDA approval in mid-December helped the market continue its northerly …
ETF Tracker Newsletter For November 20, 2020
ETF Tracker StatSheet You can view the latest version here. BARFING INTO THE CLOSE [Chart courtesy of MarketWatch.com] Moving the markets An early rally in the Nasdaq ran out of steam late in the session with the index following the Dow and S&P 500 via a sudden swan dive into the red. The usual culprits contributed to the lackluster …
Weekly StatSheet For The ETF Tracker Newsletter – Updated Through 11/19/2020
ETF Data updated through Thursday, November 19, 2020 Methodology/Use of this StatSheet: 1. From the universe of over 1,800 ETFs, I have selected only those with a trading volume of over $5 million per day (HV ETFs), so that liquidity and a small bid/ask spread are assured. 2. Trend Tracking Indexes (TTIs) Buy or Sell decisions for Domestic and International …
Tech Sector Stages Revival
[Chart courtesy of MarketWatch.com] Moving the markets The tech sector, which had been lagging the major indexes for a few weeks, staged a comeback today, as traders suddenly considered it to be some sort of safety play in the face of mounting Covid-19 incidents. As a result, the Nasdaq outperformed the Dow and S&P 500 by a substantial margin. For …
Losing Support And Dumping Into The Red—No Time For Complacency
[Chart courtesy of MarketWatch.com] Moving the markets The tug-of-war between vaccine giants Pfizer and Moderna shifted into overdrive with the former now besting the latter by pointing to its final analysis, which verified a 95% effective rate vs. Moderna’s previous 92%. I am sure that we have not heard the last of it. The news of that advancement was offset …